• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素通过下调雌激素反应性乳腺癌细胞中 Delta-like 配体 4 发挥抗癌作用。

Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells.

机构信息

Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

出版信息

Recent Pat Anticancer Drug Discov. 2020;15(4):329-340. doi: 10.2174/1574892815666200929145236.

DOI:10.2174/1574892815666200929145236
PMID:32990541
Abstract

BACKGROUND

The Notch signaling pathway has a key role in angiogenesis and Delta - Like Ligand 4 (DLL4) is one of the main ligands of Notch involved in cell proliferation in sprouting vessels.

OBJECTIVE

In this study, we aimed to evaluate the expression of DLL4 in primary breast tumors and to examine the effect of melatonin on DLL4 expression in vitro.

METHODS

Eighty-five breast tumor and paired adjacent non-tumor tissue samples were collected. Apoptosis assay was performed on breast cancer cells to evaluate melatonin effects. Western blot and quantitative RT-PCR were used to measure DLL4 expression. Then, we investigated the effect of melatonin on the expression of DLL4 in four breast cancer cell lines at RNA and protein levels. We also performed a probabilistic neural network analysis to study genes closely associated with DLL4 expression.

RESULTS

Our results showed a significantly higher expression of DLL4 in tumor tissues compared to non-tumor tissues (P = 0.027). Melatonin treatment substantially attenuated DLL4 expression in BT474 and MCF-7 cells, but not in SK-BR-3 and MDA-MB-231 cells. Also, melatonin induced apoptosis in all four cell lines. Network analysis revealed a set of 15 genes that had close association and interaction with DLL4. DLL4 was overexpressed in breast cancer tissues as compared to the non-tumor tissues.

CONCLUSION

It can be concluded that melatonin treatment attenuated DLL4 expression only in estrogen- responsive breast cancer cells and is able to induce apoptosis in breast cancer cells.

摘要

背景

Notch 信号通路在血管生成中具有关键作用,Delta 样配体 4(DLL4)是 Notch 的主要配体之一,参与芽生血管中的细胞增殖。

目的

本研究旨在评估 DLL4 在原发性乳腺癌肿瘤中的表达,并研究褪黑素对体外 DLL4 表达的影响。

方法

收集 85 例乳腺癌肿瘤和配对的相邻非肿瘤组织样本。对乳腺癌细胞进行凋亡实验,以评估褪黑素的作用。采用 Western blot 和定量 RT-PCR 检测 DLL4 的表达。然后,我们在四个乳腺癌细胞系中研究了褪黑素对 DLL4 表达的影响,包括 RNA 和蛋白水平。我们还进行了概率神经网络分析,以研究与 DLL4 表达密切相关的基因。

结果

我们的结果表明,肿瘤组织中 DLL4 的表达明显高于非肿瘤组织(P = 0.027)。褪黑素处理显著减弱了 BT474 和 MCF-7 细胞中 DLL4 的表达,但对 SK-BR-3 和 MDA-MB-231 细胞没有影响。此外,褪黑素诱导了所有四个细胞系的凋亡。网络分析显示了一组与 DLL4 密切关联和相互作用的 15 个基因。与非肿瘤组织相比,DLL4 在乳腺癌组织中过度表达。

结论

褪黑素治疗仅在雌激素反应性乳腺癌细胞中减弱 DLL4 表达,并能诱导乳腺癌细胞凋亡。

相似文献

1
Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells.褪黑素通过下调雌激素反应性乳腺癌细胞中 Delta-like 配体 4 发挥抗癌作用。
Recent Pat Anticancer Drug Discov. 2020;15(4):329-340. doi: 10.2174/1574892815666200929145236.
2
MicroRNA-384-5p Promotes Endothelial Progenitor Cell Proliferation and Angiogenesis in Cerebral Ischemic Stroke through the Delta-Likeligand 4-Mediated Notch Signaling Pathway.微小RNA-384-5p通过Delta样配体4介导的Notch信号通路促进脑缺血性卒中内皮祖细胞增殖和血管生成。
Cerebrovasc Dis. 2020;49(1):39-54. doi: 10.1159/000503950. Epub 2020 Jan 10.
3
The bispecific antibody HB-32, blockade of both VEGF and DLL4 shows potent anti-angiogenic activity in vitro and anti-tumor activity in breast cancer xenograft models.双特异性抗体 HB-32 阻断 VEGF 和 DLL4,在体外显示出强大的抗血管生成活性,并在乳腺癌异种移植模型中显示出抗肿瘤活性。
Exp Cell Res. 2019 Jul 15;380(2):141-148. doi: 10.1016/j.yexcr.2019.04.025. Epub 2019 Apr 26.
4
Delta-like ligand 4 (DLL4) in the plasma and neoplastic tissues from breast cancer patients: correlation with metastasis.乳腺癌患者血浆和肿瘤组织中的Delta样配体4(DLL4):与转移的相关性
Med Oncol. 2014 May;31(5):945. doi: 10.1007/s12032-014-0945-0. Epub 2014 Apr 3.
5
Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.Notch1 信号在 NOTCH1 突变型套细胞淋巴瘤中依赖于 Delta-like 配体 4,是特定抗体治疗的潜在靶点。
J Exp Clin Cancer Res. 2019 Nov 1;38(1):446. doi: 10.1186/s13046-019-1458-7.
6
Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4.乳酸受体 GPR81 通过调节细胞外基质特性和 Notch 配体 DLL4 驱动乳腺癌的生长和侵袭。
BMC Cancer. 2023 Nov 22;23(1):1136. doi: 10.1186/s12885-023-11631-6.
7
The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study.血管切迹配体Delta样配体4(DLL4)和Jagged1(JAG1)与微血管形成呈相反的相关性,但在原发性胶质母细胞瘤中具有一致的预后影响:一项初步研究。
World Neurosurg. 2016 Apr;88:447-458. doi: 10.1016/j.wneu.2015.10.058. Epub 2015 Nov 4.
8
Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia.脾脏在 DLL4 驱动的急性 T 细胞淋巴细胞白血病中起主要作用。
Theranostics. 2021 Jan 1;11(4):1594-1608. doi: 10.7150/thno.48067. eCollection 2021.
9
Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo.Delta样配体4(Dll4)可预测透明细胞肾细胞癌的预后,且抗Dll4可在体内抑制肿瘤生长。
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2143-52. eCollection 2014.
10
Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.褪黑素通过抑制乳腺癌干细胞上皮-间充质转化(EMT)抑制低氧诱导的血管生成拟态。
Eur J Pharmacol. 2020 Aug 15;881:173282. doi: 10.1016/j.ejphar.2020.173282. Epub 2020 Jun 21.

引用本文的文献

1
Melatonin: a natural guardian in cancer treatment.褪黑素:癌症治疗中的天然守护者。
Front Pharmacol. 2025 Jul 18;16:1617508. doi: 10.3389/fphar.2025.1617508. eCollection 2025.
2
Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review.三阴性乳腺癌的免疫逃逸模式及新的潜在治疗靶点:综述
Front Immunol. 2024 Dec 13;15:1513421. doi: 10.3389/fimmu.2024.1513421. eCollection 2024.
3
Apoptotic effect of melatonin on ER-positive breast cancer cell lines: ADGRL4 gene expression and promoter methylation.
褪黑素对雌激素受体阳性乳腺癌细胞系的凋亡作用:ADGRL4基因表达及启动子甲基化
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1815-1823. doi: 10.1007/s00210-024-03383-2. Epub 2024 Aug 23.
4
Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer.Notch3 和 DLL4 在人乳腺癌中的表达及预后价值。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221118984. doi: 10.1177/15330338221118984.
5
Women's health and night shift work: Potential targets for future strategies in breast cancer (Review).女性健康与夜班工作:乳腺癌未来策略的潜在目标(综述)
Biomed Rep. 2021 Dec;15(6):98. doi: 10.3892/br.2021.1474. Epub 2021 Sep 24.
6
Association of Body Mass Index With Somatic Mutations in Breast Cancer.体重指数与乳腺癌体细胞突变的关联
Front Oncol. 2021 Apr 1;11:613933. doi: 10.3389/fonc.2021.613933. eCollection 2021.